Capital Impact Advisors, LLC - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 111 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 4.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital Impact Advisors, LLC ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$312,380
-36.8%
2,1390.0%0.52%
-4.0%
Q2 2023$494,109
-29.5%
2,139
-26.0%
0.54%
-36.7%
Q1 2023$700,616
-1.6%
2,892
+17.8%
0.86%
+23.6%
Q4 2022$712,274
+25.0%
2,454
-69.9%
0.70%
+22.5%
Q3 2022$570,000
-2.4%
8,1620.0%0.57%
+5.2%
Q2 2022$584,000
-52.6%
8,162
-35.0%
0.54%
-39.7%
Q1 2022$1,232,000
-20.3%
12,556
-31.2%
0.90%
-16.0%
Q4 2021$1,546,000
+64.5%
18,249
+55.0%
1.07%
+186.1%
Q3 2021$940,000
-18.0%
11,7750.0%0.37%
+0.8%
Q2 2021$1,147,000
-70.3%
11,775
-64.4%
0.37%
-72.7%
Q1 2021$3,866,000
+42.8%
33,048
+35.7%
1.35%
+103.6%
Q4 2020$2,707,000
-1.8%
24,3510.0%0.66%
-27.8%
Q2 2020$2,758,000
+69.6%
24,3510.0%0.92%
+34.8%
Q1 2020$1,626,000
-23.6%
24,351
+4.3%
0.68%
-8.8%
Q4 2019$2,128,000
+21.4%
23,355
+13.4%
0.75%
+12.1%
Q3 2019$1,753,000
-3.8%
20,593
+13.5%
0.67%0.0%
Q2 2019$1,823,000
+27.8%
18,148
+32.9%
0.67%
+5.7%
Q1 2019$1,427,0000.0%13,6590.0%0.63%
+3.6%
Q4 2018$1,427,000
-6.7%
13,659
+89.7%
0.61%
+16.4%
Q3 2018$1,529,000
-16.7%
7,201
+9.0%
0.52%
-22.8%
Q2 2018$1,836,000
+40.5%
6,605
-41.0%
0.68%
+26.4%
Q1 2018$1,307,00011,1950.54%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$11,3428.78%
University of Wisconsin Foundation 40,133$5,861,0236.72%
Paulson & Co. 500,000$73,020,0006.53%
TCG Crossover Management, LLC 179,917$26,275,0793.87%
Avoro Capital Advisors LLC 1,555,000$227,092,2003.54%
Affinity Asset Advisors, LLC 85,000$12,413,4003.49%
Ghost Tree Capital, LLC 57,500$8,397,3002.76%
Lynwood Capital Management Inc. 5,000$730,2001.92%
MPM BioImpact LLC 40,859$5,967,0481.59%
Tri Locum Partners LP 33,761$4,930,4561.58%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders